Buy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared Holz

January 14, 2025
Buy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared HolzBuy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared Holz

Jared Holz, Mizuho, joins ‘Fast Money’ to talk how to play Eli Lilly’s stock right now.

Share This

Latest Mizuho News

Prefer Novo short-term as a GLP-1 play, says Mizuho’s Jared Holz

Prefer Novo short-term as a GLP-1 play, says Mizuho’s Jared Holz

April 20, 2026
Iran war highlights risks in the chemical supply chain

Iran war highlights risks in the chemical supply chain

April 15, 2026
Wall Street jumps to near one-month highs after US-Iran ceasefire

Wall Street jumps to near one-month highs after US-Iran ceasefire

April 8, 2026

Mizuho news from around the globe

back-to-top-blue